Send to a friend

Victoria Maroulis is a partner in the Silicon Valley Office.  Mrs. Maroulis is Co-Chair of the firm's National Life Science Practice.  Her practice primarily focuses on intellectual property litigation.  She has litigated and provided counseling for companies on a broad range of patent, copyright, trademark, and trade secrets matters.  She has litigated a number of significant patent cases, including multi-party and MDL cases for such clients as General Electric, Cisco, Oracle, Genentech, and Monsanto.  She has extensive experience in managing complex patent litigation in a variety of technologies including software, hardware, semiconductors, medical devices and biotechnology.  She has chaired bench and jury trials and argued several appeals.  She is a member of the bars of New York and California and is admitted to the Eastern District of Texas, Trial Bar of the Northern District of Illinois, and Federal Circuit.  Victoria is an active member of the local legal community.  She regularly lectures on IP matters, judges regional mock trial and moot court competitions, and has taught trial practice at Stanford Law School, the in house Quinn Emanuel program, and the ABA trial training for legal aid attorneys.  In 2010, Victoria was selected as one of 10 Intellectual Property Rising Stars under 40 nationwide by Law360.  She has also been named as one of the top 100 women litigators in California by The Daily Journal.  In 2011, Victoria was featured in The American Lawyer’s “45 under 45” list of outstanding female attorneys.

In the fields of Biotechnology and Medical Devices, she has represented  Genentech, Monsanto, Bio-Rad, and GE Healthcare.

In the Software, Hardware, Networking and Semiconductors fields, she has represented AOL, IBM, Cisco, NETGEAR, D-Link, Belkin, NetSuite, Nuance, Oracle, Samsung, Borland Software, and Macrovision.

On behalf of Genentech, won summary judgment of non-infringement on all claims of two patents asserted by Sanofi-Aventis Deutschland against two highly successful anti-cancer products. 

On behalf of Cisco, Belkin, NETGEAR, and D-Link, won complete summary judgment of non-infringement and invalidity in a patent infringement case relating to wireless routers.

On behalf of Genentech, secured only the second writ of mandamus ever to be issued by the Federal Circuit in the seminal In re Genentech case in relation to a motion to transfer venue from the Eastern District of Texas to the Northern District of California.

Obtained a complete victory for Cisco in a closely watched patent infringement dispute where plaintiff asserted a patent on a method for Voice over Internet Protocol telephony against Cisco’s line of Integrated Services Routers.   Prevailed on a motion to dismiss the complaint for lack of standing, on the ground that the patent was related to the former employer’s business, ownership was automatically transferred to the employer under the assignment agreement. 

Represented twenty-three cell phone manufacturers – including Motorola, Samsung and Sony Ericsson – accused by the University of Texas of infringing a patent relating to text messaging using Touch-Tone telephones. The University alleged that the manufacturers infringed its patent by incorporating predictive text messaging software into over 400 models of cell phones. Several defendants – not represented by our firm – settled identical claims for $3.27 for each cell phone sold in the United States. The potential liability to the clients therefore approached $2 billion.

Represented Genentech in a multi-district patent litigation concerning recombinant DNA technology and the process of co-transformation to produce proteins in mammalian cells.  Obtained a broad covenant not to sue, and by agreeing to the covenant, the patentee permanently surrendered a claim against the client for hundreds of millions of dollars in royalties.

Represented AOL's subsidiary, Tegic Communications, in a patent suit against an infringing competitor. After a three-week jury trial involving complex text input software technology, defeated the attack on the validity of two Tegic patents and won a unanimous jury verdict of willful infringement and $9 million in compensatory damages.

Represented Monsanto in a patent infringement matter when the plaintiff patentee, a local public university, alleged that our client’s recombinant bovine growth hormone product infringed its patent and sought $1.8 billion in treble damages and a permanent injunction. After winning a summary judgment eliminating one of the two accused products, and limiting the literal coverage of the claims to technology “known and available” in 1980, the case settled favorably the day before the jury trial was to start.

Represented AstraZeneca in a patent infringement action involving cancer medication.  Obtained summary judgment on the patent misuse defense.

Represented Kmart Corporation, winning a bench trial upholding its multi-million dollar contract with its co-branded credit card partner.  For the same client, obtained dismissal with prejudice, on the eve of trial, of a multi-million dollar lease dispute brought against it.

Represented IBM, obtaining a favorable settlement during a bench trial in a multi-million dollar breach-of-contract action involving third-party equipment leasing.

Represented Borland Software Corporation in a trademark infringement action where the plaintiff sought $250 million dollars and permanent injunctive relief.  Was able to obtain a favorable pre-trial settlement.

Represented several media companies, including AOL Time Warner and The Columbia House Company, in a Section 17200 unfair competition suit alleging millions of dollars in damages arising from the collection of use taxes on the shipping and handling costs of compact discs, tapes, videos, DVDs and other similar products.  Obtained a dismissal with prejudice at the pleading stage.